Royalty Report. Within ​ days following the end of each Calendar Quarter in which Net Sales occurred, Zai Lab will calculate and report to INCY the actual amount of royalties accrued for the subject Calendar Quarter. Each such report (“Quarterly Royalty Report”) will state on a Licensed Product-by-Licensed Product and Region-by-Region basis: # ​, # ​, and # ​.

Sales and Royalty Report. Within ​ days after each quarter during the Royalty Term, Buyer will provide to Seller a Sales and Royalty Report, together with a payment of all Royalties payable on Net Sales during such quarter.

Royalty Report. For each Calendar Quarter for which Roche has an obligation to make royalty payments pursuant to [Section 8.8], within ​ after the end of such Calendar Quarter, ​. Each royalty payment made by Roche pursuant to [Section 8.8] shall be accompanied by a report that specifies, on a per-Therapeutic Product or per-Licensed Product basis, for such Calendar Quarter the following information:

Royalty Report and Payment. Within ​ after the end of each Calendar Quarter, commencing with the first Calendar Quarter in which there is any sale of the Product anywhere in the Territory, Ji Xing shall provide [[Cytokinetics:Organization]] with a report that contains the following information for the applicable Calendar Quarter, on a Market-by-Market basis: # the amount of gross sales of the Product, # an itemized calculation of Net Sales showing separately each type of deduction provided for in the definition of “Net Sales,” # a calculation of the royalty payment due on such sales in Dollars, including the exchange rate and any reduction under [Section 9.4(c), and (iv)])] the aggregate Net Sales of the past twelve (12) months and whether any sales milestone has been achieved. Concurrent with the delivery of the applicable quarterly report, Ji Xing shall pay to [[Cytokinetics:Organization]] in Dollars the royalties owed with respect to Net Sales for such Calendar Quarter.

Royalty Report. On or before the due date of each payment pursuant to Section 6.3.1, [[PolyOne:Organization]] shall deliver to Integral a true and accurate written report showing (the “Royalty Report”):

Royalty Payment. After the receipt of each royalty report provided by Zai under Section 9.4(d) above, TPTX shall issue to Zai an invoice for the amount of Royalty Payment set forth therein. Zai shall pay to TPTX the royalties for each Calendar Quarter within ​ days after the receipt of the invoice from TPTX. If no royalty is due for any Calendar Quarter following commencement of the reporting obligation, Zai shall so report.

Royalty Report and Payment. Within ​ after each Calendar Quarter in which the First Commercial Sale of any Product occurs in the Territory, Bausch Health shall provide Clearside with a report that contains the following information for the applicable Calendar Quarter, on a Product-by-Product and country-by-country basis: # the amount of gross sales of Products, # the gross selling price and the number of units of all Products sold in each country of the Territory, # an itemized calculation of Net Sales showing separately each type of reduction provided for in the definition of “Net Sales”, # a calculation of the royalty payment due on such Net Sales in Dollars, including the exchange rate, where applicable, and # whether any of the milestone payments under [Section 8.1(c)] above has been earned during such Calendar Quarter. Concurrent with the delivery of the applicable quarterly report, Bausch Health shall pay to Clearside in Dollars the royalties owed with respect to Net Sales for such Calendar Quarter and, if applicable, the payment of any milestone payments under [Section 8.1(c)] that has been earned during such Calendar Quarter.

Payment Date Report. On each Reporting Date, the Facility Servicer shall provide to the Administrative Agent and the Initial Lender a Payment Date Report containing the information set forth on (and substantially in the form of) [Exhibit D], including the amounts to be remitted pursuant to [Section 2.08] to the applicable parties on the related Payment Date (which shall include any applicable wiring instructions of the parties receiving payment) with respect to such Payment Date.

Royalty Report and Payment. Within ​ after the end of each Calendar Quarter, commencing with the first Calendar Quarter in which there is any sale of the Product anywhere in the Territory, Ji Xing shall provide [[Cytokinetics:Organization]] with a report that contains the following information for the applicable Calendar Quarter, on a Market-by-Market basis: # the amount of gross sales of the Product, # an itemized calculation of Net Sales showing separately each type of deduction provided for in the definition of “Net Sales,” # a calculation of the royalty payment due on such sales in Dollars, including the exchange rate and any reduction under Section 9.4(c), and (iv) the aggregate Net Sales of the past twelve (12) months and whether any sales milestone has been achieved. Concurrent with the delivery of the applicable quarterly report, Ji Xing shall pay to [[Cytokinetics:Organization]] in Dollars the royalties owed with respect to Net Sales for such Calendar Quarter.

Royalty Payment. During the Royalty Term, Zai shall pay to TPTX tiered royalties as calculated by multiplying the applicable royalty rate set forth in the table below by the corresponding amount of incremental, aggregated Net Sales of all Products in the Territory in a Calendar Year (a “Royalty Payment”). The tiered royalty rates on Net Sales shall be as set forth below: